BeStock  
Stocks › Biotechnology › ALMS

Alumis ALMS

US equityMarket cap rank #3330Biotechnology
$6.77 −$0.16 (-2.31%)
Pre-market · Oct 8, 9:10 am ET · After hours $6.77 0.00%
Open$6.82
Prev close$6.93
Day range$6.71 – $6.95
Volume2.17M
Market cap$876.28M
P/E (TTM)–
Dividend yield–

ALMS Stock News

Headlines matching Alumis or the ALMS ticker, most recent first.

  • Analysts' Top Healthcare Picks: UniQure (QURE), Alumis Inc. (ALMS)TipRanks · 3 Sep 2026 · Direct mention
  • Raymond James Maintains Alumis(ALMS.US) With Buy RatingMarket news · 3 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Alumis Inc. (ALMS)TipRanks · 3 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Alumis(ALMS.US), With a Forecast Between $15 to $37Market news · 3 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)TipRanks · 2 Sep 2026 · Direct mention
  • Wells Fargo Sticks to Its Buy Rating for Alumis Inc. (ALMS)TipRanks · 10 Sep 2026 · Direct mention
  • Alumis(ALMS.US) Director Buys US$10.73 Million in Common StockMarket news · 10 Sep 2026 · Direct mention
  • Wells Fargo Maintains Alumis(ALMS.US) With Buy Rating, Maintains Target Price $25Market news · 10 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Alumis(ALMS.US) With Buy Rating, Maintains Target Price $39Market news · 17 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS), Cabaletta Bio (CABA) and Capricor Therapeutics (CAPR)TipRanks · 14 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), Satellos Bioscience (MSLE) and Alumis Inc. (ALMS)TipRanks · 14 Aug 2026 · Direct mention
  • Guggenheim Keeps Their Buy Rating on Alumis Inc. (ALMS)TipRanks · 14 Aug 2026 · Direct mention
  • Stifel Maintains Alumis(ALMS.US) With Buy Rating, Maintains Target Price $44Market news · 14 Aug 2026 · Direct mention
  • Guggenheim Maintains Alumis(ALMS.US) With Buy Rating, Maintains Target Price $34Market news · 14 Aug 2026 · Direct mention
  • Alumis Inc. (ALMS) Receives a Rating Update From a Top AnalystTipRanks · 13 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ALMS.

Leave a comment

Scroll to Top